Literature DB >> 19774688

Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas.

Mario Alejandro Lorenzetti1, Marina Inés Gutiérrez, Jaime Altcheh, Guillermo Moscatelli, Samanta Moroni, Paola Andrea Chabay, María Victoria Preciado.   

Abstract

Epstein-Barr virus genotypes can be distinguished by polymorphic variations in the genes encoding EBNA2, 3A, 3B, and 3C. The immediate early gene BZLF1 plays a key role in modulating the switch from latency to lytic replication and therefore enabling viral propagation. The aim of this study was to investigate and compare BZLF1 promoter sequence (Zp) variation in pediatric infectious mononucleosis (IM) and in pediatric EBV positive lymphoma biopsies. Zp was sequenced from peripheral blood mononuclear cells (PBMC) and throat swabs from 10 patients with IM at the time of diagnosis (D0) and during convalescence; and from 13 lymphoma biopsies. Zp - P and Zp - V3 variants were found in eight and one IM patients, as well as in five and six tumor biopsies, respectively. A correlation between viral genotype and Zp variant was found significant for Zp - V3 and EBV2 (P = 0.0002). One IM patient harbored two concomitant Zp variants. Regardless of anatomical compartment or stage of disease all IM patients displayed the same Zp variant along the course of the study. No new infections or adaptative selection of different variants was evidenced. A new Zp variant (Zp - V3 + 49) was described in two Hodgkin lymphomas, but not in IM. This is the first study to describe Zp variants compartmentalization in children with acute EBV infection and convalescence in a developing country; and comparing them with Zp variants in pediatric lymphomas from the same geographic area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774688     DOI: 10.1002/jmv.21616

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Authors:  Mario Alejandro Lorenzetti; Magdalena Gantuz; Jaime Altcheh; Elena De Matteo; Paola Andrea Chabay; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-12-17       Impact factor: 0.196

Review 3.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

4.  Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.

Authors:  Aldana G Vistarop; Melina Cohen; Elena De Matteo; María Victoria Preciado; Paola A Chabay
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

5.  A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

Authors:  Jillian A Bristol; Reza Djavadian; Emily R Albright; Carrie B Coleman; Makoto Ohashi; Mitchell Hayes; James C Romero-Masters; Elizabeth A Barlow; Paul J Farrell; Rosemary Rochford; Robert F Kalejta; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2018-07-27       Impact factor: 6.823

6.  Spatial Dispersal of Epstein-Barr Virus in South America Reveals an African American Variant in Brazilian Lymphomas.

Authors:  Paula Alves; Marcella Larrate; Aruanã Garcia-Costa; Paulo Rohan; Bianca Ervatti Gama; Eliana Abdelhay; Edson Delatorre; Rocio Hassan
Journal:  Viruses       Date:  2022-08-12       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.